The efficacy of fecal microbiota transplantation (FMT) in Alzheimer's disease has yet to be investigated. Here, we show that FMT is capable of providing neuroprotective effects in two groups of treated 5xFAD Alzheimer's mice, old transgenic (Tg) mice fed fecal slurry from healthy, wild-type donors of similar age (Old Tg-FO) and old mice fed fecal slurry from younger healthy, wild-type donors (Old Tg-FY). Improved spatial and recognition memory in Old Tg-FY and 15 enhanced recognition memory in Old Tg-FO were observed when compared to Old Tg-Control mice given saline. Crucially, there was significant decreases in cortical Ab loading in all treated mice, demonstrating the therapeutic effects of FMT in improving cognition and reducing amyloid pathology in AD brains.
Main Text: Alzheimer's disease (AD) is a progressive neurodegenerative condition resulting in cognitive, behavioral and functional decline with a predementia phase termed mild cognitive impairment (MCI) (1, 2) . The pathological hallmarks of AD include extracellular deposition of amyloid-b (Ab) peptide and intracellular accumulation of the hyperphosphorelated microtubuleassociated protein tau into neurofibrillary tangles (NFT). Evidence suggests that these two 5 pathological deposits are potentially involved in feedback loops where each causes further deposition of the other (3, 4) leading to synaptic degeneration (5, 6) . Although genetic risk factors have been well-established in early-onset AD (6) (7) (8) (9) , various other causal mechanisms have been associated with the development of the more prevalent, sporadic form of AD, including obesity (10) , increased plasma cholesterol and type 2 diabetes mellitus (11, 12) . 10 The human microbiome has been described to have a distinct, complex role in the pathophysiology of multiple diseases (13) . Inter-individual variation (14) as well as age-dependent changes (15) in the human gut microbiome have been described, with Firmicutes and Bacteroidetes identified as the predominant phyla while gut microbial involvement has been suggested in neurodevelopmental (16, 17) , autoimmune (18) , movement (19, 20) and neurodegenerative (20, 15 21) disorders. Recent studies have proven gut microbial involvement in the development of AD (22) . Altering gut microbe composition in Alzheimer's mice via long-term antibiotic administration resulted in decreased cerebral Ab loading (23) while removal and recolonization of gut microbiota resulted in decreased and increased amyloid loading respectively (24). Furthermore, the composition of bacterial populations in fecal samples of AD patients is markedly 20 different from healthy individuals in the abundance of certain phyla and genera, with AD patients observed to have increased Bacteroidetes and decreased Firmicutes and Bifidobacterium levels (25). Hence the involvement of intestinal microbiota in the development and progression of AD has been established, although its exact role has not yet been delineated. FMT involves the transfer of fecal material from a healthy donor to a recipient with the aim of normalizing composition and therefore function of intestinal microbial populations (26). FMT has been successfully used to treat recurrent Clostridium difficile infections (27) with expansions of its application into the treatment of other gastrointestinal disorders (28). The efficacy of FMT has also been described in reducing 5 intestinal dysbiosis in Parkinson's mice (9) and alleviating psychiatric disorders (29), although its effects in AD has not as of yet been described.
To understand the impact of FMT in a murine model of AD, we performed the procedure via oral gavage in twenty-three 5xFAD (30-32 weeks) recipient mice using fecal matter from healthy B6SJL wildtype donor mice (10-12 and 30-32 week-old) over a period of seven days. Eight of the 10 old recipient mice received oral gavage of fecal slurry obtained from healthy, wild-type donor mice of the same age (Old Tg-fed old; Old Tg-FO) and eight received oral gavage of fecal slurry from healthy, younger wild-type donors (Old Tg-fed young; Old Tg-FY). The control 5xFAD recipient mice (30-32 weeks old; n = 7) were gavaged with normal saline (Old Tg-Control).
Following an incubation period of 21 days, mice were subjected to behavioral testing to study the 15 effects of FMT on cognition, after which cerebral Ab levels were evaluated histologically.
Behavioral studies were also performed on healthy wildtype mice who did not exhibit AD phenotype and served as positive controls for comparison against normal behavior (Old-WT).
Cognitive ability was assessed as the degree of anxiety, recognition memory and spatial memory.
Emotional symptoms such as anxiety arise from Ab and tau accumulation in the amygdala (30) 20 and can be assessed by means of the elevated plus maze (EPM) (31) while dorsal hippocampal involvement in recognition and spatial memory formation and hippocampal degeneration during the course of AD are evaluated by the novel object recognition (NOR) (32). Synaptic degeneration of the CA1 field in the hippocampus, innervated by pyramidal neurons from the entorhinal cortex, results in spatial memory decline in AD mice (33, 34) which is also apparent in hippocampal atrophy and neuron loss seen in AD patients (35) and is evaluated in the form of a forced alternation Y-maze (FAY) (31). Following treatment, Old Tg-FY mice were found to have overall improved cognition and Old Tg-FO displayed some cognitive improvements. The increasing trend in 5 cognitive improvement observed in the Old groups correlate with decreased Ab loading. showed a small increase in this ratio (p=0.477), with levels somewhat identical to age-matched 15 WT littermates (n= 4; Fig 1b) indicating a much higher preference for the Novel Object compared to control (Fig 1c) (36).
The FAY results were analyzed in the form of time spent in the Novel Arm and ratio of Novel to Other arm entries. Old Tg-FO animals showed a significant, near two-fold increase (p=0.046) while Old Tg-FY demonstrated a significant two-fold increase (p=0.030) in time spent in the Novel Arm (Fig 2d) . Compared to the Old-WT mice who were used as a standard, the Old treated groups spent even more time exploring the Novel Arm. When comparing the ratio of Novel:Other arm entries, Old Tg-FO mice also displayed an approximately two-fold, statistically significant increase (p=0.012) in preference for the Novel arm while Old Tg-FY mice 5 demonstrated a nearly three-fold, statistically significant increase (p=0.012) in preference (Fig 2e) (36). Compared to the Old-WT mice, both groups of Old-treated animals showed a higher sense of exploratory behavior, demonstrated by a greater ratio of Novel:Other arm entries (Fig 1e) (36).
Ab plaque loading was evaluated using Thioflavin S staining and analyzed as the percentage area of cortical amyloid plaque and quantified as the number of cortical plaques. Old The amygdala interacts with the hippocampus and hypothalamus to influence the hypothalamicpituitary-adrenal axis which is involved in the regulation of the stress hormones such as cortisol. 5 A reduction of dysbiosis of intestinal microbiota could result in restoration of permeability of the intestinal epithelium and possibly the normalization of cortisol levels via the gut-brain axis, causing a decrease of anxiety levels, especially in Old Tg-FY mice. Furthermore, FMT may allow for increased clearance or renewal of clearance mechanisms of Ab from the amygdala which could result in reduced anxiety. The overall results of the EPM show a trend towards normalization of 10 anxiety to levels similar to that observed in age-matched wildtype mice.
The NOR involves exposure to an object (Familiar Object) for 5 minutes in Phase 1, followed by an interval and subsequently, exposure to the Familiar Object and a Novel Object for 5 minutes.
To understand object preference in the mice, we calculated the DI which assigns a numerical value indicating object preference. The more negative the number, the lesser the preference for the Novel 15 Object. Old Tg-FO and Old Tg-FY groups both demonstrated increases in the DI, indicating improved recognition memory sensitivity (37) in the treated groups compared to controls. Our results indicate the restoration of hippocampal function to a certain extent in treated groups, possibly related to increased hippocampal Ab clearance. Treated groups demonstrate a reversal in recognition memory deficits to levels comparable to wildtype littermates in the NOR. 20 The procedure for the FAY was similar to the NOR, involving an initial phase where mice were given 5 minutes to explore the 3-arm maze with a single arm blocked from entry. In Phase 2 mice had access to all 3 arms. Old Tg-FO and Old Tg-FY showed remarkable improvement in spatial memory following FMT, with increases in both the percentage of time spent in the Novel Arm and the ratio of Novel arm entries to other arm entries (Fg 1d-e). The FAY results demonstrate that FMT is particularly efficient in improving spatial memory, indicating its potency in restoring hippocampal function. Similar to the EPM and NOR results, the FAY outcomes demonstrate that FMT may be facilitating Ab clearance, allowing for improved spatial memory. 5 Decrease in Ab levels was investigated quantitatively using Thioflavin S staining. Thioflavin 
.
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